Phosphoenolpyruvate carboxykinase 1 mRNA 3'-untranslated region (PCK1 mRNA 3'-UTR)

The PCK1 mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the messenger RNA encoding phosphoenolpyruvate carboxykinase 1, the rate-limiting enzyme in cytosolic gluconeogenesis. This region contains binding sites for various microRNAs (such as miR-29 and miR-214) and RNA-binding proteins that dictate the stability and translational efficiency of the PCK1 transcript (Source: PubMed, PMID: 21832034). Because PCK1 is often overexpressed in states of insulin resistance, leading to excessive hepatic glucose production, the 3'-UTR serves as a strategic therapeutic target for RNA-based interventions. By utilizing antisense oligonucleotides or miRNA mimics to target this region, researchers aim to lower blood glucose levels in patients with type 2 diabetes (Source: NIH, PubChem). This approach offers a method to modulate metabolic flux by reducing enzyme synthesis rather than inhibiting the catalytic activity of the protein directly.

Other names

PEPCK-C mRNA 3'-UTRPCK1 3'-UTRPhosphoenolpyruvate carboxykinase (GTP) mRNA 3'-UTRCytosolic phosphoenolpyruvate carboxykinase mRNA 3'-UTR

Targeting the 3'-UTR of PCK1 mRNA typically involves the use of antisense oligonucleotides (ASOs) or microRNA mimics to induce RNase H-mediated degradation of the transcript or to inhibit translation, thereby reducing the levels of the PCK1 enzyme and decreasing hepatic glucose production.